Beware the cowboy cloners
By Hilary Rose,
The Guardian
| 02. 16. 2004
Here we go again. Reading the excited claims for the medical
benefits likely to accrue from the Korean veterinary researchers'
success in growing cloned human pre-embryos, one is entitled
to feeling a certain deja vu. Heading the list were those old
favourites, treatments for Parkinson's and Alzheimer's disease.
There really needs to be a phrase to describe this researchers'
equivalent of the old charge against doctors of shroud waving.
After all, only a few weeks back we were told that the planned
primate research centre in Cambridge was crucial in the search
for treatments for just the same diseases. The truth is that
no one knows if stem cells - the intended end product of therapeutic
cloning - will have such curative powers, still less the solution
to the spinal injuries Christopher Reeve was hoping for in Friday's
Guardian. The right way to find out - the way biomedical research
normally proceeds - is to try the methods first with laboratory
animals. And so far their success, even for the best-understood
condition - Parkinson's - has been limited. This isn't...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...